Letermovir prophylaxis against CMV after HCT

03.13.23

Letermovir prophylaxis against CMV after HCT

by ASTCT Science Highlights

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

03.09.23

Combining TIGIT inhibition with immunomodulary drugs may prevent MM progression after SCT

by ASTCT Science Highlights

Viral-Specific T cell use in SCD patients post-HSCT

03.02.23

Viral-Specific T cell use in SCD patients post-HSCT

by ASTCT Science Highlights

T-cell immunotherapies upregulate MHC-II surface expression on AML cells

02.21.23

T-cell immunotherapies upregulate MHC-II surface expression on AML cells

by ASTCT Science Highlights

Liso-cel as second-line therapy for large B-cell lymphoma

02.14.23

Liso-cel as second-line therapy for large B-cell lymphoma

by ASTCT Science Highlights

Romiplostim impact post-auto HCT for multiple myeloma or lymphoma

02.02.23

Romiplostim impact post-auto HCT for multiple myeloma or lymphoma

by ASTCT Science Highlights

Infusion of Memory T cells after haplo-HSCT

01.19.23

Infusion of Memory T cells after haplo-HSCT

by ASTCT Science Highlights

Microbiota injury related to Conditioning Regimens

12.22.22

Microbiota injury related to Conditioning Regimens

by ASTCT Science Highlights

Impact of pre-HCT therapy on outcome in patients with AML

12.20.22

Impact of pre-HCT therapy on outcome in patients with AML

by ASTCT Science Highlights

Theme picker